Form 4: HeartBeam Director Marga Ortigas-Wedekind Buys Shares

Director Marga Ortigas-Wedekind acquired 25,000 shares of HeartBeam, Inc. common stock at $0.80 per share.

Summary

• Director Marga Ortigas-Wedekind purchased 25,000 shares of HeartBeam, Inc. (BEAT) common stock.
• The transaction occurred on April 16, 2026, at a price of $0.80 per share.
• The purchase was made in connection with the company's underwritten public offering of 12,500,000 shares.
• Following this transaction, the director's total beneficial ownership is 137,293 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive signal, as insider buying during a public offering indicates management's commitment to the company's future.

Positives

• Insider confidence is demonstrated by a director purchasing shares in the company's public offering.
• The purchase aligns the director's interests with those of shareholders.

Negatives

• NA

Risks

• The investment is subject to the general market risks associated with HeartBeam's business and the volatility of its stock price.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that director participation in public offerings is generally viewed as a positive signal of management confidence in the company's long-term strategic direction and capital structure.

Comparison to Industry Standards

• Director participation in equity offerings is a standard practice for aligning leadership with shareholder interests in the medical technology sector.

Stakeholder Impact

• Shareholders may view the director's investment as a vote of confidence in the company's recent capital raise.

Next Steps

• None mentioned.

Key Dates

Recommendation

While insider buying is a positive signal, this is a routine disclosure of participation in a public offering rather than an independent open-market purchase, warranting a hold recommendation until further operational milestones are achieved.

Keywords

HeartBeam, BEAT, Insider Trading, Form 4, Director Purchase, Public Offering